Cargando…
COVID-19 in Patients with Hematologic Diseases
The COVID-19 outbreak had a strong impact on people’s lives all over the world. Patients with hematologic diseases have been heavily affected by the pandemic, because their immune system may be compromised due to anti-cancer or immunosuppressive therapies and because diagnosis and treatment of their...
Autores principales: | Casetti, Ilaria Carola, Borsani, Oscar, Rumi, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775038/ https://www.ncbi.nlm.nih.gov/pubmed/36551825 http://dx.doi.org/10.3390/biomedicines10123069 |
Ejemplares similares
-
Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination
por: Borsani, Oscar, et al.
Publicado: (2022) -
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance
por: Rumi, Elisa, et al.
Publicado: (2020) -
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023) -
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
por: Vanni, Daniele, et al.
Publicado: (2022) -
Isolated congenital asplenia: An overlooked cause of thrombocytosis
por: Borsani, Oscar, et al.
Publicado: (2022)